Market open · Delayed intraday data · 2:59 PM ET
Last update: Sep 1, 2026, 2:48 PM ET
McKesson Corporation
$908.32 2.60% today
Market Open

Why McKesson Corporation (MCK) stock moved

Updated Sep 1, 2026

McKesson Corporation (MCK) shares rose 2.6% to $908.32 as of September 1, 2026, a moderate gain from the prior close of $885.32. BestStocks flagged the session as a major change for MCK. Below, we break down what changed for MCK, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

MCK climbed 2.6% to $908.32

McKesson gained 2.28% to $905.53, supported by positive investor sentiment following its announced $2.25 billion acquisition of Precision Medicine Group and raised fiscal guidance driven by strong oncology and specialty pharma growth. The company also declared a 15% increase to its quarterly dividend to $0.94 per share, effective September 1, 2026. Trading volume of 112,841 shares sits below the 70-minute average (0.61x expected), suggesting the move reflects deliberate accumulation rather than broad institutional rush. MCK earnings on November 4, 2026 (consensus EPS estimate $10.76); monitor for updates on Precision Medicine Group acquisition closing timeline and any refinement to raised guidance in subsequent quarterly reports.

This summary describes the catalyst and move as first detected on Sep 1, 2026, 10:43 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
ActivityLow confidence
Rel. volume
0.3×
Below Avg
Vs peers
No comparable peers
Market cap
$106.3B
New York Stock Exchange
Analyst target
$972
+7.0% vs price
Price chart
Aug 3 – Sep 1
VEEEVFEVEVV$825$868$910Aug 3Aug 10Aug 18Aug 25Sep 1
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for McKesson Corporation investors

For McKesson Corporation investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 2.6% session move. Weighing against that: MCK moved -4.47% from its $912.19 open to a $871.38 close on 2026-08-06; McKesson Corporation (MCK) moved -3.16% from $818.66 to $792.81 on 2026-07-09. Wall Street's consensus price target sits at $971.63, implying +7.0% upside from $908.32. BestStocks rates the overall signal quality low (41/100). With earnings roughly 64 days out, the next report is the most likely near-term test of the move.

MCK price reaction

MCK last traded at $908.32, up $23.00 (+2.60%) from the previous close of $885.32. The session traded on 0.3× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $827.14 and $908.32, and it currently sits about 100% of the way up that band.

Bullish and bearish analyst opinions on McKesson Corporation (MCK)

Latest catalyststrengthens the bull case
The latest catalyst — a materially positive development — it strengthens the bull case.

The consensus analyst price target on McKesson Corporation (MCK) is $971.63, 7.0% above the recent $908.32. Over the past 90 days analysts logged 0 upgrades, 8 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MCK line up.

The bullish case

  • Wall Street's consensus price target of $971.63 implies +7.0% upside from $908.32.
  • The Street's most bullish target is $1,085.00 (+19.5%).
  • Material positive event.
  • Positive 2.6% session move.
  • Positive price momentum.

The bearish case

  • The most bearish analyst target is $845.00 (-7.0%).
  • MCK moved -4.47% from its $912.19 open to a $871.38 close on 2026-08-06.
  • McKesson Corporation (MCK) moved -3.16% from $818.66 to $792.81 on 2026-07-09.
Bull vs bear balanceBullish Shift
BearishNeutralBullish
The latest catalyst moved the balance toward the bulls — the hollow tick marks where it sat before.

Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Sep 1, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $972+7.0%
= 8 maintains
Barclays maintained Overweight · 2026-08-19
SEC filings watch
8-K2026-08-05
Material event — review for impact
high
10-Q2026-08-05
Quarterly financial results
medium
8-K2026-07-24
Material event — review for impact
high
8-K2026-07-01
Material event — review for impact
high
Peer context
MCK+2.6%

Previous notable changes for MCK

Material / Earnings2026-08-25+3.6%
McKesson Corporation (MCK) moved +3.87% from $871.40 to $905.09 on 2026-08-25. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move coincided with MCK reaching a new 30-day high; volume remained near its 5-day average.
Material / Earnings2026-08-21+2.4%
McKesson Corporation (MCK) moved +2.27% from $839.84 to $858.90 on 2026-08-21. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move coincided with volume 2.0x the 5-day average, suggesting institutional accumulation or technical-driven buying.
Material / Earnings2026-08-12-2.6%
McKesson Corporation (MCK) moved -2.57% from $901.90 to $878.73 on 2026-08-12. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Valuation2026-08-11+2.5%via Yahoo Finance
McKesson reported fiscal Q1 2027 earnings that beat expectations, with adjusted EPS of $9.93 versus consensus of $9.64, and revenue of $105.38 billion, up 8% year-over-year and above forecasts. Management raised full-year adjusted EPS guidance to $44.20–$45.00, citing strong growth in North American Pharmaceutical and Oncology/Specialty care segments. The stock rose 2.08% to $898.14 on the earnings beat and raised outlook.
Upcoming catalysts & outlook
Next earnings
2026-11-04 (est.)
in 64 days
10-K Annual Report (est.)
2027-05-08
Medium impact
Thesis shift
Bullish Shift
bullish signal
Risk level
High
from change events

Frequently asked questions about MCK

Why did McKesson Corporation (MCK) stock move?

MCK rose 2.6% to $908.32. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did MCK stock rise?

MCK gained 2.60% ($23.00) versus the prior close of $885.32, last trading at $908.32 on 0.3× average volume.

When is McKesson Corporation's next earnings date?

MCK's next earnings report is estimated for 2026-11-04 — about 64 days away.

What is the analyst price target for MCK?

The consensus analyst price target for MCK is $971.63, about 7.0% above the current $908.32. Over the past 90 days, analysts recorded 0 upgrades, 8 maintains, and 0 downgrades.

How BestStocks tracks MCK

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared MCK-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for MCK, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 1, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.